CD142+ MPs were higher in CF patients (3.84 ± 1.48%, 8.75 ± 6.04% and 19.28 ± 4.94% for the controls, DN and CF groups; respectively; p < 0.001, Fig. 1D). This evidence concerns the gene F3 and cystic fibrosis.